High Throughput Screening (HTS) Market Analysis, Competitive Landscape and Forecast 2025
13th Aug 2019 – The global high throughput screening (HTS) market size is anticipated to value at USD 30.91 billion by 2025, during the forecast period. HTS market is subject to show a substantial growth due to the growing emphasis on drug discovery and development coupled with increasing investment by governmental agencies and research institutes. With recent advancement in technology and growing need for automation for liquid handling, formation of innovative platforms, and improvements in existing analytical tools allows to handle large sets of data, thus driving growth of the high throughput screening (HTS) market exponentially. Furthermore, rising competition between various healthcare and pharmaceutical organizations to revolutionize drug discovery is catering to the growth of the HTS market in coming years.
Constant demand for high throughput screening (HTS) in research and production areas is further propelling growth of the HTS market. Globally, the high throughput screening (HTS) market is predicted to grow at CAGR of 7.89% in forecast period, providing numerous opportunities for market players to invest for research and development in the HTS market. High throughput screening, commonly referred as a high content screening (HCS), majorly adopted to carry out various genetic, biochemical, and pharmacology studies to help in the drug discovery procedure involving drug design to medicine trails and analysis of the effects caused by drug interactions. High throughput screening (HTS) procedure consists of high-tech software, numerous instruments to manage liquids, and other detectors to allows rapid identification of active materials, genetic modifications, and biochemical interactions.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/high-throughput-screening-hts-market/request-sample
Mounting demand for highly effective therapies to cure various diseases has led to the adoption of technology in drug discovery. Monitoring of large amount of processed data and screening are some of the critical processes that has to be handled with high precision to achieve required outcome. The latest trends in the drug discovery involves formation of numerous biochemical libraries to establish set of standards and record results, thus escalating growth of the high throughput screening (HTS) market. Though, adoption of such procedure require specific set of skillset and advanced software to manage and save large amount of data at high speed, lack of which hampers growth of the high throughput screening (HTS) market.
Numerous governmental and private agencies are assigned to monitor stringent quality checks and standards to attain required integrity and precision for the obtained data, thus fueling growth of the HTS market over forecast period. Yet, unavailability advanced software to control automated instruments and liquid handling systems is significantly hampering growth of the market. Nevertheless, one of the biggest advantage associated with the use of the high throughput screening (HTS) is reduction of time to formulate a drug discovery.
High Throughput Screening (HTS) is widely known drug discovery technique, that is commonly adopted in the pharmaceutical and healthcare sector. High throughput screening (HTS) allows use of automation for faster examination and analysis of the biological and chemical activities of numerous compounds that are used for production and discovery of drugs. Application of the high throughput screening (HTS) involves discovering molecular receptors, various enzymes, ion channels and identification of a chemical pathway. HTS is made feasible for drug discovery due to modern advancement in robotics and high-speed computing technique.
The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise adoption of latest methodologies in the healthcare sector for R&D purposes and existence well-established market players in the region.
Asia-Pacific region is predicted to hold major market share in the high throughput screening (HTS) industry with massive growth in forecast period. Countries such as India, China and Japan are leading the Asia-Pacific market with recent technological advancements in drug discovery techniques with the use of 3D-cell cultures and substantial investment by prominent industry players due to potential opportunities in the region.
The key players in the high throughput screening (HTS) market are Agilent Technologies Incorporations, Danaher Co., Thermofisher Scientific Incorporations, PerkinElmer Incorporations, Tecan Group Limited, Hamilton Company, and Aurora Biomed Co.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Research Support Specialist, USA
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Visit Our Blog: https://latestmarketstudy.wordpress.com